A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

Phase 3 Completed 321 enrolled Forest Laboratories Cypress Bioscience, Inc. · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is designed to accurately assess any changes in blood pressure and pulse at 100 and 200 mg daily dose of milnacipran in patients with fibromyalgia syndrome.

Timeline

Start: 2007-10
Primary completion: 2008-07
Completion: —

Publications

Trugman JM, Palmer RH, Ma Y. Milnacipran effects on 24-hour ambulatory blood pressure and heart rate in fibromyalgia patients: a randomized, placebo-controlled, dose-escalation study. Curr Med Res Opin. 2014 Apr;30(4):589-97. doi: 10.1185/03007995.2013.861812. Epub 2013 Nov 20.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Milnacipran	Other / unclassified	200 mg	Oral

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

Summary

Timeline

Publications

Drugs

Indications